Nausea, constipation, fatigue and other frequent side effects of GLP-1 medications, what the trial data say about how common they are, and practical strategies people use with their provider's guidance.
Most people who start a GLP-1 medication will notice at least one digestive side effect in the first few months. That is not a sign something has gone wrong; it is a direct consequence of how the medication works. Slower stomach emptying and a quieter appetite are the same mechanisms that produce fullness and, when they overshoot, nausea or constipation. This article explains what the data say about how common these effects are, when they tend to happen, and the strategies people commonly use. It is general education, not personal advice, and any persistent or severe symptom belongs in a conversation with your licensed provider.
The prescribing information gives the clearest numbers. In the Wegovy label, the most common adverse reactions at the 2.4 mg dose versus placebo were:
The Zepbound label shows the same categories: nausea in 25 to 29 percent of participants across doses (8 percent placebo), diarrhea 19 to 23 percent, constipation 11 to 17 percent, vomiting 8 to 13 percent. Dyspepsia, belching, reflux, injection site reactions and hair loss were also reported more often than placebo.
Two patterns matter more than the raw numbers. First, the SURMOUNT-1 investigators noted that gastrointestinal events were mostly mild to moderate and occurred "primarily during dose escalation." Second, discontinuation because of side effects was uncommon: 4.3 to 7.1 percent across tirzepatide doses versus 2.6 percent on placebo. Most people get through the adjustment period.
Nausea is the signature side effect, and it is usually tied to meals. The 2024 nutritional guidance from Almandoz and colleagues, published in Obesity, and the general advice in the prescribing information point to the same practical themes:
The labels note that if a dose increase is not tolerated, the prescriber can delay escalation. That decision belongs to the licensed provider; adjusting or splitting doses on your own is one of the behaviors the FDA has linked to adverse event reports with compounded products.
Occasional vomiting or loose stools are unpleasant but manageable. Repeated episodes are a different matter. Both labels carry a warning about acute kidney injury caused by volume depletion, meaning fluid loss severe enough to reduce blood flow to the kidneys. Several cases in postmarketing reports required hospitalization.
Practical steps people use:
The CDC notes that the body needs more water during vomiting, diarrhea, fever, heat and physical activity, all of which stack on top of the reduced thirst and appetite that these medications can produce.
Constipation gets less attention than nausea but is often more persistent. Slower gut transit, eating less overall, and drinking less (because you feel full) combine to slow things down. The strategies in the nutritional guidance are familiar: adequate fluids, gradually increasing dietary fiber from vegetables, fruit, legumes and whole grains, and regular movement, which stimulates the bowel. Over-the-counter options such as fiber supplements or stool softeners are commonly used, but a licensed provider or pharmacist should confirm what is appropriate alongside your other medications.
Fatigue appears in the labels at 11 percent for semaglutide and is listed for tirzepatide as well. There are several plausible contributors: a significant drop in calorie intake, dehydration, poor sleep during the adjustment period, and, in people with diabetes on other glucose-lowering medications, low blood sugar. Spreading protein and complex carbohydrates across the day rather than eating one small meal, keeping fluids up, and keeping activity light but regular in the first weeks are the usual starting points. Fatigue that is severe or accompanied by other symptoms deserves evaluation rather than guesswork.
Food lingering in the stomach can push acid upward. Smaller meals, avoiding carbonated drinks, and leaving two to three hours between the last meal and bedtime are the most common adjustments. Persistent heartburn should be discussed with a provider rather than treated indefinitely with over-the-counter antacids.
Redness, itching or a small lump at the injection site is listed in the tirzepatide label. Rotating sites among the abdomen, thigh and upper arm, letting refrigerated medication reach room temperature briefly before injecting, and not injecting into bruised or irritated skin are standard practices covered in the patient instructions supplied with the medication.
Hair loss appears in both labels at low single-digit percentages. It is generally understood as telogen effluvium, a temporary shedding triggered by rapid weight loss and reduced nutrient intake rather than a direct drug effect, although the mechanism is not fully established. Adequate protein and overall nutrition are the usual recommendations. Shedding that is heavy or prolonged warrants a conversation with a provider, since other causes such as thyroid or iron issues should be ruled out.
The prescribing information describes several situations that need prompt medical attention rather than self-management:
Anyone having surgery or a procedure with sedation should also tell the care team they are on a GLP-1 medication, because of the aspiration risk from delayed stomach emptying.
Side effects are a normal topic for follow-up visits, not something to push through silently. Prescribers routinely slow escalation, hold at a dose, or adjust timing based on how someone is tolerating treatment, and those adjustments work better with accurate reporting. Keeping a simple log of symptoms, timing relative to injection day, and what you ate can make the conversation far more useful.
For most people, gastrointestinal effects appear during dose escalation and ease over weeks. The SURMOUNT-1 investigators reported they occurred primarily during dose escalation and were mostly mild to moderate.
Common approaches are smaller portions eaten slowly, stopping at the first sign of fullness, lower-fat meals, not lying down right after eating, and bland or cool foods when nausea is active. If a dose increase is not tolerated, the prescriber can delay escalation.
Hair loss appears in both labels at low single-digit percentages. It is generally understood as temporary shedding triggered by rapid weight loss and lower nutrient intake, though the mechanism is not fully established. Heavy or prolonged shedding should be discussed with a provider.
Seek prompt care for severe, persistent abdominal pain; upper right abdominal pain, fever or yellowing skin; swelling of the face or throat or trouble breathing; dehydration that does not improve with fluids; vision changes in people with diabetes; or a neck lump, hoarseness or trouble swallowing.
If side effects are affecting your daily life, your hydration, or your ability to eat enough protein, a licensed provider can help you decide what to change. This article is educational only and does not replace that conversation or determine whether any medication is appropriate for you.
Written by the NewDay Wellness editorial team from the sources above and checked against them before publication, and medically reviewed by Dr. Sean Arora and Dr. Shannon Arora of Arora Health & Aesthetics; see our editorial standards. This article is educational and does not diagnose conditions, establish eligibility for any medication, or replace care from a licensed provider. Compounded medications are not FDA-approved.
The first weeks on a GLP-1 usually mean a low starting dose that your prescriber raises gradually, a quieter appetite, and for many people mild to moderate digestive side effects. Knowing what is common and what to report makes the start easier.
Read articleWhen appetite drops, the quality of each meal matters more. A practical guide to protein, fiber, fluids and micronutrients while taking a GLP-1 medication, drawn from published clinical guidance.
Read article
You can travel, celebrate and eat out on a GLP-1 medication with some planning: keep medication in your carry-on and follow your pharmacy's storage instructions, order smaller portions, keep fluids up, and ask your prescriber how to handle timing changes.
Read article